Literature DB >> 26361958

Identification of expression quantitative trait loci of RPTOR for susceptibility to glioma.

Liming Huang1, Wenshen Xu2, Danfang Yan3, Lian Dai4, Xi Shi5.   

Abstract

Expression quantitative trait loci (eQTLs) have been recognized to be more likely to associate with complex diseases including cancer. As an essential scaffold for MTOR complex 1, RPTOR is necessary for the MTOR-catalyzed phosphorylation. This study examined the associations between the eQTLs of RPTOR and glioma susceptibility. The eQTLs of RPTOR were obtained from GTEx eQTL Browser. Associations were estimated by logistic regression models. On the basis of analysis of 138 cases with glioma and 327 cancer-free population controls, we demonstrated that the eQTL of RPTOR, rs7502563, was significantly associated with a decreased glioma risk [odds ratio (OR) = 0.59, 95 % confidence interval (CI) = 0.38-0.89, P = 0.0123] in a dominant manner. Stratified analyses indicated that the association between rs7502563 and glioma was more pronounced in females (OR = 0.40, 95 % CI = 0.20-0.80, P = 0.0091), older subjects (OR = 0.47, 95 % CI = 0.26-0.86, P = 0.0135), and subjects with high-grade glioma (OR = 0.45, 95 % CI = 0.27-0.77, P = 0.0031). Moreover, an interest gradual decrease in OR with higher grade glioma was observed. Further analysis of the extracted data from GTEx eQTL Browser found that rs7502563 G allele was associated with significantly higher expression of RPTOR in all HapMap populations. Our results demonstrate for the first time that the eQTL of RPTOR, rs7502563, is susceptible to glioma.

Entities:  

Keywords:  Expression quantitative trait locus; Genetic susceptibility; Glioma; RPTOR

Mesh:

Substances:

Year:  2015        PMID: 26361958     DOI: 10.1007/s13277-015-3956-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

Authors:  Y Sonoda; T Ozawa; K D Aldape; D F Deen; M S Berger; R O Pieper
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

2.  Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.

Authors:  Kathryn K Bercury; JinXiang Dai; Hilary H Sachs; Jared T Ahrendsen; Teresa L Wood; Wendy B Macklin
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

3.  Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.

Authors:  T Kubiatowski; T Jang; M B Lachyankar; R Salmonsen; R R Nabi; P J Quesenberry; N S Litofsky; A H Ross; L D Recht
Journal:  J Neurosurg       Date:  2001-09       Impact factor: 5.115

4.  Fas engagement increases expression of interleukin-6 in human glioma cells.

Authors:  Chulhee Choi; G Yancey Gillespie; Nicholas J Van Wagoner; Etty N Benveniste
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

5.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

6.  S6K1 plays a key role in glial transformation.

Authors:  Jean L Nakamura; Edna Garcia; Russell O Pieper
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

7.  Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.

Authors:  Xuerong Wang; Ping Yue; Young Ae Kim; Haian Fu; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Dissecting eIF4E action in tumorigenesis.

Authors:  Hans-Guido Wendel; Ricardo L A Silva; Abba Malina; John R Mills; Hong Zhu; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga; Julie Teruya-Feldstein; Jerry Pelletier; Scott W Lowe
Journal:  Genes Dev       Date:  2007-11-30       Impact factor: 11.361

10.  Interleukin-6 gene amplification and shortened survival in glioblastoma patients.

Authors:  A Tchirkov; T Khalil; E Chautard; K Mokhtari; L Véronèse; B Irthum; P Vago; J-L Kémény; P Verrelle
Journal:  Br J Cancer       Date:  2007-01-16       Impact factor: 7.640

View more
  4 in total

1.  Genetic Predisposition to Glioma Mediated by a MAPKAP1 Enhancer Variant.

Authors:  Liming Huang; Wenshen Xu; Danfang Yan; Xin You; Xi Shi; Shu Zhang; Hualan Hong; Lian Dai
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

2.  Identification of expression quantitative trait loci of MTOR associated with the progression of glioma.

Authors:  Liming Huang; Lian Dai; Wenshen Xu; Shu Zhang; Danfang Yan; Xi Shi
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

3.  Mapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosus.

Authors:  Christopher A Odhams; Andrea Cortini; Lingyan Chen; Amy L Roberts; Ana Viñuela; Alfonso Buil; Kerrin S Small; Emmanouil T Dermitzakis; David L Morris; Timothy J Vyse; Deborah S Cunninghame Graham
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

4.  An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility.

Authors:  Liming Huang; Wenshen Xu; Lian Dai; Danfang Yan; Shu Zhang; Xi Shi
Journal:  Cancer Manag Res       Date:  2018-09-27       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.